Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Samsung Biologics Co Ltd (Samsung Biologics) is pharmaceutical company that provide contract development, manufacturing, and laboratory testing services. The company offers development services such as late discovery, cell line development, process development, analytical development, non-good manufacturing practice and current good manufacturing practice manufacturing. It also provides manufacturing services, quality services and analytical testing services. Samsung Biologics technology platform includes S-DUAL, DEVELOPICK, S-CHOsient, S-CHOice, S-Tensify, S-Glyn and S-OptiCharge. It has operations in South Korea, Japan and the US. Samsung Biologics is headquartered in Incheon, South Korea.
Headquarters
South Korea
Address
300, Songdo Bio-Daero, Yeonsu-Gu, Incheon, 21987
Website
samsungbiologics.com
Telephone
82 32 4553114
No of Employees
5,455
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
207940 (KRX)
Revenue (2024)
$3.2B
30.3%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
64.7%
(2024 vs 2023)
Market Cap*
$42.7B
Net Profit Margin (2024)
XYZ
26.4%
(2024 vs 2023)
* As of and is in US$
Samsung Biologics Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Platforms: | Development | S-DUAL |
| S-DUAL | Late Discovery | DEVELOPICK |
| DEVELOPICK | Cell Line Development | S-CHOsient |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Acquisitions/Mergers/Takeovers | In July, the company acquired a global peptide CDMO (Contract Development and Manufacturing Organization). |
| 2026 | Plans/Strategy | In July, the company announced its plans to acquire a 100% stake in PolyPeptide Group AG. |
| 2026 | Contracts/Agreements | In March, the company signed an agreement with Eli Lilly and Company to open the Lilly Gateway Labs site in Korea. |
Competitor Comparison
| Key Parameters | Samsung Biologics Co Ltd | Celltrion Inc | Avid Bioservices Inc | Binex Co Ltd | Eubiologics Co Ltd |
|---|---|---|---|---|---|
| Headquarters | South Korea | South Korea | United States of America | South Korea | South Korea |
| City | Incheon | Incheon | Tustin | Busan | Seoul |
| State/Province | - | Gangwon | California | Yeongnam | - |
| No. of Employees | 5,455 | 1,074 | 371 | 390 | 397 |
| Entity Type | Public | Public | Private | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John Rim | Chairman; Chief Executive Officer; President | Executive Board | 2020 | - |
| Seung Ho Ryu | Chief Financial Officer; Director; Executive Vice President | Executive Board | 2025 | - |
| Kun Lo, Ph.D | Director; Executive Vice President | Executive Board | 2023 | - |
| James Choi | Chief Marketing Officer; Executive Vice President; Head - Sales Support, Project Management, and Global Public Affairs | Senior Management | 2014 | - |
| Kevin Sharp | Executive Vice President; Head - Sales and Operations Department | Senior Management | 2017 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer